Kannaway, the direct promoting subsidiary of Medical Marijuana, Inc., introduced that its Japan and South Africa divisions reached their largest income month in firm historical past throughout January 2022. 

“With the ability to obtain 4 finest income months in a row within the Japan market has been each a good way to finish 2021 and an inspiring option to begin 2022,” stated Medical Marijuana, Inc. CEO Blake Schroeder. “Now that we’ve reached this milestone in South Africa as properly, we anticipate that each areas might be main market areas for us this yr and past.” 

Kannaway factors to a projection by Enterprise Insider Africa, that estimates the African hashish trade will develop past a $7 billion valuation by 2023, as proof that the corporate’s development within the area might quickly develop exponentially.